カテゴリー： QYResearch, 世界, 部品/材料

世界の医療用生体適合性材料市場インサイト及び予測（ピーク、PPSU）

◆英語タイトル：Global Medical Biocompatible Material Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX01533）◆商品コード：QY22JLX01533
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：112
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、医療用生体適合性材料のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に医療用生体適合性材料の世界市場のxxx％を占める「ピーク」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「整形外科」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
医療用生体適合性材料の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの医療用生体適合性材料市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

医療用生体適合性材料のグローバル主要企業には、Victrex (Invibio)、Solvay、Evonik、Ensinger Group、Superior Polymers、Quadrant、China-uju、Changchun JUSEP、ZYPEEK、JHPEEKなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

医療用生体適合性材料市場は、種類と用途によって区分されます。世界の医療用生体適合性材料市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ピーク、PPSU

【用途別セグメント】
整形外科、歯科、外傷、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 医療用生体適合性材料製品概要
- 種類別市場（ピーク、PPSU）
- 用途別市場（整形外科、歯科、外傷、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の医療用生体適合性材料販売量予測2017-2028
- 世界の医療用生体適合性材料売上予測2017-2028
- 医療用生体適合性材料の地域別販売量
- 医療用生体適合性材料の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別医療用生体適合性材料販売量
- 主要メーカー別医療用生体適合性材料売上
- 主要メーカー別医療用生体適合性材料価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（ピーク、PPSU）
- 医療用生体適合性材料の種類別販売量
- 医療用生体適合性材料の種類別売上
- 医療用生体適合性材料の種類別価格
・用途別市場規模（整形外科、歯科、外傷、その他）
- 医療用生体適合性材料の用途別販売量
- 医療用生体適合性材料の用途別売上
- 医療用生体適合性材料の用途別価格
・北米市場
- 北米の医療用生体適合性材料市場規模（種類別、用途別）
- 主要国別の医療用生体適合性材料市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの医療用生体適合性材料市場規模（種類別、用途別）
- 主要国別の医療用生体適合性材料市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の医療用生体適合性材料市場規模（種類別、用途別）
- 主要国別の医療用生体適合性材料市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の医療用生体適合性材料市場規模（種類別、用途別）
- 主要国別の医療用生体適合性材料市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの医療用生体適合性材料市場規模（種類別、用途別）
- 主要国別の医療用生体適合性材料市場規模（トルコ、サウジアラビア）
・企業情報
Victrex (Invibio)、Solvay、Evonik、Ensinger Group、Superior Polymers、Quadrant、China-uju、Changchun JUSEP、ZYPEEK、JHPEEK
・産業チェーン及び販売チャネル分析
- 医療用生体適合性材料の産業チェーン分析
- 医療用生体適合性材料の原材料
- 医療用生体適合性材料の生産プロセス
- 医療用生体適合性材料の販売及びマーケティング
- 医療用生体適合性材料の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 医療用生体適合性材料の産業動向
- 医療用生体適合性材料のマーケットドライバー
- 医療用生体適合性材料の課題
- 医療用生体適合性材料の阻害要因
・主な調査結果

Market Analysis and Insights: Global Medical Biocompatible Material Market
Due to the COVID-19 pandemic, the global Medical Biocompatible Material market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, PEEK accounting for % of the Medical Biocompatible Material global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Orthopedics segment is altered to an % CAGR throughout this forecast period.
China Medical Biocompatible Material market size is valued at US$ million in 2021, while the US and Europe Medical Biocompatible Material are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medical Biocompatible Material landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Medical Biocompatible Material include Victrex (Invibio), Solvay, Evonik, Ensinger Group, Superior Polymers, Quadrant, China-uju, Changchun JUSEP and ZYPEEK and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Medical Biocompatible Material capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Medical Biocompatible Material by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Medical Biocompatible Material Scope and Segment
Medical Biocompatible Material market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Medical Biocompatible Material market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
PEEK
PPSU
Segment by Application
Orthopedics
Dental
Trauma
Other
By Company
Victrex (Invibio)
Solvay
Evonik
Ensinger Group
Superior Polymers
Quadrant
China-uju
Changchun JUSEP
ZYPEEK
JHPEEK
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Medical Biocompatible Material Product Introduction
1.2 Market by Type
1.2.1 Global Medical Biocompatible Material Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 PEEK
1.2.3 PPSU
1.3 Market by Application
1.3.1 Global Medical Biocompatible Material Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Orthopedics
1.3.3 Dental
1.3.4 Trauma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Medical Biocompatible Material Production
2.1 Global Medical Biocompatible Material Production Capacity (2017-2028)
2.2 Global Medical Biocompatible Material Production by Region: 2017 VS 2021 VS 2028
2.3 Global Medical Biocompatible Material Production by Region
2.3.1 Global Medical Biocompatible Material Historic Production by Region (2017-2022)
2.3.2 Global Medical Biocompatible Material Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Medical Biocompatible Material Sales in Volume & Value Estimates and Forecasts
3.1 Global Medical Biocompatible Material Sales Estimates and Forecasts 2017-2028
3.2 Global Medical Biocompatible Material Revenue Estimates and Forecasts 2017-2028
3.3 Global Medical Biocompatible Material Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Medical Biocompatible Material Sales by Region
3.4.1 Global Medical Biocompatible Material Sales by Region (2017-2022)
3.4.2 Global Sales Medical Biocompatible Material by Region (2023-2028)
3.5 Global Medical Biocompatible Material Revenue by Region
3.5.1 Global Medical Biocompatible Material Revenue by Region (2017-2022)
3.5.2 Global Medical Biocompatible Material Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Medical Biocompatible Material Production Capacity by Manufacturers
4.2 Global Medical Biocompatible Material Sales by Manufacturers
4.2.1 Global Medical Biocompatible Material Sales by Manufacturers (2017-2022)
4.2.2 Global Medical Biocompatible Material Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Biocompatible Material in 2021
4.3 Global Medical Biocompatible Material Revenue by Manufacturers
4.3.1 Global Medical Biocompatible Material Revenue by Manufacturers (2017-2022)
4.3.2 Global Medical Biocompatible Material Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Medical Biocompatible Material Revenue in 2021
4.4 Global Medical Biocompatible Material Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Medical Biocompatible Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Medical Biocompatible Material Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Medical Biocompatible Material Sales by Type
5.1.1 Global Medical Biocompatible Material Historical Sales by Type (2017-2022)
5.1.2 Global Medical Biocompatible Material Forecasted Sales by Type (2023-2028)
5.1.3 Global Medical Biocompatible Material Sales Market Share by Type (2017-2028)
5.2 Global Medical Biocompatible Material Revenue by Type
5.2.1 Global Medical Biocompatible Material Historical Revenue by Type (2017-2022)
5.2.2 Global Medical Biocompatible Material Forecasted Revenue by Type (2023-2028)
5.2.3 Global Medical Biocompatible Material Revenue Market Share by Type (2017-2028)
5.3 Global Medical Biocompatible Material Price by Type
5.3.1 Global Medical Biocompatible Material Price by Type (2017-2022)
5.3.2 Global Medical Biocompatible Material Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Medical Biocompatible Material Sales by Application
6.1.1 Global Medical Biocompatible Material Historical Sales by Application (2017-2022)
6.1.2 Global Medical Biocompatible Material Forecasted Sales by Application (2023-2028)
6.1.3 Global Medical Biocompatible Material Sales Market Share by Application (2017-2028)
6.2 Global Medical Biocompatible Material Revenue by Application
6.2.1 Global Medical Biocompatible Material Historical Revenue by Application (2017-2022)
6.2.2 Global Medical Biocompatible Material Forecasted Revenue by Application (2023-2028)
6.2.3 Global Medical Biocompatible Material Revenue Market Share by Application (2017-2028)
6.3 Global Medical Biocompatible Material Price by Application
6.3.1 Global Medical Biocompatible Material Price by Application (2017-2022)
6.3.2 Global Medical Biocompatible Material Price Forecast by Application (2023-2028)
7 North America
7.1 North America Medical Biocompatible Material Market Size by Type
7.1.1 North America Medical Biocompatible Material Sales by Type (2017-2028)
7.1.2 North America Medical Biocompatible Material Revenue by Type (2017-2028)
7.2 North America Medical Biocompatible Material Market Size by Application
7.2.1 North America Medical Biocompatible Material Sales by Application (2017-2028)
7.2.2 North America Medical Biocompatible Material Revenue by Application (2017-2028)
7.3 North America Medical Biocompatible Material Sales by Country
7.3.1 North America Medical Biocompatible Material Sales by Country (2017-2028)
7.3.2 North America Medical Biocompatible Material Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Medical Biocompatible Material Market Size by Type
8.1.1 Europe Medical Biocompatible Material Sales by Type (2017-2028)
8.1.2 Europe Medical Biocompatible Material Revenue by Type (2017-2028)
8.2 Europe Medical Biocompatible Material Market Size by Application
8.2.1 Europe Medical Biocompatible Material Sales by Application (2017-2028)
8.2.2 Europe Medical Biocompatible Material Revenue by Application (2017-2028)
8.3 Europe Medical Biocompatible Material Sales by Country
8.3.1 Europe Medical Biocompatible Material Sales by Country (2017-2028)
8.3.2 Europe Medical Biocompatible Material Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Medical Biocompatible Material Market Size by Type
9.1.1 Asia Pacific Medical Biocompatible Material Sales by Type (2017-2028)
9.1.2 Asia Pacific Medical Biocompatible Material Revenue by Type (2017-2028)
9.2 Asia Pacific Medical Biocompatible Material Market Size by Application
9.2.1 Asia Pacific Medical Biocompatible Material Sales by Application (2017-2028)
9.2.2 Asia Pacific Medical Biocompatible Material Revenue by Application (2017-2028)
9.3 Asia Pacific Medical Biocompatible Material Sales by Region
9.3.1 Asia Pacific Medical Biocompatible Material Sales by Region (2017-2028)
9.3.2 Asia Pacific Medical Biocompatible Material Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Medical Biocompatible Material Market Size by Type
10.1.1 Latin America Medical Biocompatible Material Sales by Type (2017-2028)
10.1.2 Latin America Medical Biocompatible Material Revenue by Type (2017-2028)
10.2 Latin America Medical Biocompatible Material Market Size by Application
10.2.1 Latin America Medical Biocompatible Material Sales by Application (2017-2028)
10.2.2 Latin America Medical Biocompatible Material Revenue by Application (2017-2028)
10.3 Latin America Medical Biocompatible Material Sales by Country
10.3.1 Latin America Medical Biocompatible Material Sales by Country (2017-2028)
10.3.2 Latin America Medical Biocompatible Material Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Medical Biocompatible Material Market Size by Type
11.1.1 Middle East and Africa Medical Biocompatible Material Sales by Type (2017-2028)
11.1.2 Middle East and Africa Medical Biocompatible Material Revenue by Type (2017-2028)
11.2 Middle East and Africa Medical Biocompatible Material Market Size by Application
11.2.1 Middle East and Africa Medical Biocompatible Material Sales by Application (2017-2028)
11.2.2 Middle East and Africa Medical Biocompatible Material Revenue by Application (2017-2028)
11.3 Middle East and Africa Medical Biocompatible Material Sales by Country
11.3.1 Middle East and Africa Medical Biocompatible Material Sales by Country (2017-2028)
11.3.2 Middle East and Africa Medical Biocompatible Material Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Victrex (Invibio)
12.1.1 Victrex (Invibio) Corporation Information
12.1.2 Victrex (Invibio) Overview
12.1.3 Victrex (Invibio) Medical Biocompatible Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Victrex (Invibio) Medical Biocompatible Material Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Victrex (Invibio) Recent Developments
12.2 Solvay
12.2.1 Solvay Corporation Information
12.2.2 Solvay Overview
12.2.3 Solvay Medical Biocompatible Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Solvay Medical Biocompatible Material Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Solvay Recent Developments
12.3 Evonik
12.3.1 Evonik Corporation Information
12.3.2 Evonik Overview
12.3.3 Evonik Medical Biocompatible Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Evonik Medical Biocompatible Material Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Evonik Recent Developments
12.4 Ensinger Group
12.4.1 Ensinger Group Corporation Information
12.4.2 Ensinger Group Overview
12.4.3 Ensinger Group Medical Biocompatible Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Ensinger Group Medical Biocompatible Material Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Ensinger Group Recent Developments
12.5 Superior Polymers
12.5.1 Superior Polymers Corporation Information
12.5.2 Superior Polymers Overview
12.5.3 Superior Polymers Medical Biocompatible Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Superior Polymers Medical Biocompatible Material Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Superior Polymers Recent Developments
12.6 Quadrant
12.6.1 Quadrant Corporation Information
12.6.2 Quadrant Overview
12.6.3 Quadrant Medical Biocompatible Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Quadrant Medical Biocompatible Material Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Quadrant Recent Developments
12.7 China-uju
12.7.1 China-uju Corporation Information
12.7.2 China-uju Overview
12.7.3 China-uju Medical Biocompatible Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 China-uju Medical Biocompatible Material Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 China-uju Recent Developments
12.8 Changchun JUSEP
12.8.1 Changchun JUSEP Corporation Information
12.8.2 Changchun JUSEP Overview
12.8.3 Changchun JUSEP Medical Biocompatible Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Changchun JUSEP Medical Biocompatible Material Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Changchun JUSEP Recent Developments
12.9 ZYPEEK
12.9.1 ZYPEEK Corporation Information
12.9.2 ZYPEEK Overview
12.9.3 ZYPEEK Medical Biocompatible Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 ZYPEEK Medical Biocompatible Material Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 ZYPEEK Recent Developments
12.10 JHPEEK
12.10.1 JHPEEK Corporation Information
12.10.2 JHPEEK Overview
12.10.3 JHPEEK Medical Biocompatible Material Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 JHPEEK Medical Biocompatible Material Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 JHPEEK Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Medical Biocompatible Material Industry Chain Analysis
13.2 Medical Biocompatible Material Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Medical Biocompatible Material Production Mode & Process
13.4 Medical Biocompatible Material Sales and Marketing
13.4.1 Medical Biocompatible Material Sales Channels
13.4.2 Medical Biocompatible Material Distributors
13.5 Medical Biocompatible Material Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Medical Biocompatible Material Industry Trends
14.2 Medical Biocompatible Material Market Drivers
14.3 Medical Biocompatible Material Market Challenges
14.4 Medical Biocompatible Material Market Restraints
15 Key Finding in The Global Medical Biocompatible Material Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の医療用生体適合性材料市場インサイト及び予測（ピーク、PPSU）(Global Medical Biocompatible Material Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 生体適合性TPEのグローバル市場予測2023-2029
  • 生体適合性コーティング剤のグローバル市場予測2023-2029
  • ポリサルホン製品のグローバル市場2023年：PES、PSU、PPSU
  • 世界の医療用生体吸収性材料市場インサイト及び予測（PLA、PGA、PCL、多糖類、その他）
  • 世界の医療用生体吸収性ポリマー＆材料市場インサイト及び予測（PLA、PGA、PCL、多糖類、その他）